OncoQuest Pharmaceuticals Inc (078590) — Financial Flexibility Index
OncoQuest Pharmaceuticals Inc (078590) has a Financial Flexibility Index of -0.07x as of March 2026. Free cash flow of ₩-1.28 Billion (operating CF ₩-1.42 Billion minus capex ₩138.01 Million) represents 0% of total liabilities (₩19.38 Billion). Check OncoQuest Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OncoQuest Pharmaceuticals Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for OncoQuest Pharmaceuticals Inc across 10 annual periods. For the full cash flow conversion analysis, see OncoQuest Pharmaceuticals Inc (078590) cash flow conversion.
Annual Financial Flexibility Index for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year free cash flow to debt coverage for OncoQuest Pharmaceuticals Inc. Explore 078590 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | ₩1.67 Billion | ₩485.35 Million | ₩32.66 Billion | ▼ -78.4% |
| 2024 | 0.24x | ₩6.48 Billion | ₩3.96 Billion | ₩27.40 Billion | ▼ -80.5% |
| 2023 | 1.21x | ₩13.08 Billion | ₩11.19 Billion | ₩10.77 Billion | ▲ +1163.8% |
| 2022 | 0.10x | ₩896.43 Million | ₩-236.91 Million | ₩9.33 Billion | ▲ +289.5% |
| 2019 | -0.05x | ₩-2.39 Billion | ₩-4.26 Billion | ₩47.21 Billion | ▼ -180.6% |
| 2018 | 0.06x | ₩2.77 Billion | ₩1.44 Billion | ₩43.95 Billion | ▼ -89.4% |
| 2017 | 0.59x | ₩6.07 Billion | ₩4.79 Billion | ₩10.21 Billion | ▼ -16.2% |
| 2016 | 0.71x | ₩5.15 Billion | ₩3.54 Billion | ₩7.26 Billion | ▼ -14.2% |
| 2015 | 0.83x | ₩5.70 Billion | ₩2.79 Billion | ₩6.89 Billion | ▲ +262.1% |
| 2014 | 0.23x | ₩2.19 Billion | ₩1.02 Billion | ₩9.61 Billion | — |